Zoetis™ Declares Third-Quarter 2013 Dividend
June 20 2013 - 4:45PM
Business Wire
The Board of Directors of Zoetis Inc. (NYSE: ZTS), formerly the
animal health business of Pfizer Inc., has declared a third-quarter
dividend payable to holders of the company’s common stock of $0.065
per share. The dividend is to be paid on Sept. 2, 2013, to holders
of record on Aug. 1, 2013.
About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company,
dedicated to supporting its customers and their businesses.
Building on a 60-year history as the animal health business of
Pfizer, Zoetis discovers, develops, manufactures and markets
veterinary vaccines and medicines, with a focus on both farm and
companion animals. The company generated annual revenues of $4.3
billion in 2012. It has more than 9,300 employees worldwide and a
local presence in approximately 70 countries, including 29
manufacturing facilities in 11 countries. Its products serve
veterinarians, livestock producers and people who raise and care
for farm and companion animals in 120 countries.
DISCLOSURE NOTICE: This news
release contains forward-looking statements, which reflect Zoetis’
current views with respect to business plans or prospects, future
operating or financial performance, and other future events. These
statements are not guarantees of future performance.
Forward-looking statements are subject to risks and uncertainties.
If one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.
A further list and description of risks, uncertainties and other
matters can be found in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2012, including in the sections
thereof captioned “Forward-Looking Information and Factors That May
Affect Future Results” and “Item 1A. Risk Factors”, and in our
reports on Form 8-K. These filings and subsequent filings are
available online at www.sec.gov or on request from Zoetis.
Zoetis Inc.Media:Bill Price,
1-973-443-2742 (o)william.price@zoetis.comorElinore White,
1-973-443-2835 (o)elinore.y.white@zoetis.comorInvestor:Dina Fede, 1-973-443-2929 (o)orJohn
O’Connor, 1-973-822-7088 (o)
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024